Back to today’s briefing

Story perspectives

Spore. Bio Secures $23M to Revolutionize Microbiology Testing

2/20/2025

40 6

Summary

Story summary

Spore. Bio, a groundbreaking startup from Paris, has successfully raised $23 million in Series A funding, bringing its total to $31.3 million. With a mission to transform microbiology testing in food, pharmaceuticals, and cosmetics, they’re slashing testing times from days to mere minutes through cutting-edge machine learning. Already partnering with 200 factories, Spore. Bio is poised for significant growth by 2025.

1 of 1

Story summary

Spore. Bio, a groundbreaking startup from Paris, has successfully raised $23 million in Series A funding, bringing its total to $31.3 million. With a mission to transform microbiology testing in food, pharmaceuticals, and cosmetics, they’re slashing testing times from days to mere minutes through cutting-edge machine learning. Already partnering with 200 factories, Spore. Bio is poised for significant growth by 2025.